Explore how locoregional immunotherapy using bispecific antibodies and CD28 costimulation is revolutionizing low-grade B-cell lymphoma treatment.
Discover how combining immunomodulatory drugs with targeted antibodies creates a powerful one-two punch against lymphoma in recent research.